Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX By Ogkologos - March 11, 2025 778 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source RELATED ARTICLESMORE FROM AUTHOR High HPV Vaccination Coverage in England Associated with a Substantial Reduction in Cervical Cancer Mortality FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic TNBC Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions MOST POPULAR Lazertinib Demonstrates Significant Efficacy Improvement Compared with Gefitinib in the First-Line... July 17, 2023 A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic... May 12, 2026 New on NCI’s Website for July 2023 – Researcher/Trainee Special Edition July 21, 2023 Age and Frailty Should Be Considered Independently When Evaluating Potential Risk... June 27, 2022 Load more HOT NEWS Study Aims to Reduce Lung Cancer Stigma by Teaching Health Professionals... Scientists developing urine and blood tests to detect brain tumours FDA Approves Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma “Scars are Tattoos with Better Stories”
